- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Dx & Vx Co Ltd (180400)
Track today's live Dx Vx (180400) share price, performance and key data on this page with our current KOSDAQ:180400 stock exchange information. Analyse interactive charts and historical data, check technical buy and sell signals in real time, and follow the Dx Vx share price on the KOSDAQ exchange. Use the dropdown to switch exchange for the 180400 share price, head to our technical summary section, which provides analysis on Dx Vx share price buy/sell indicators using real-time data (or discuss the Dx Vx (180400) stock price today with other investors in the Dx Vx KQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current KQ:180400 share price (ISIN: KR7180400004) to enhance your trading decisions with our free investment tools and resources.
What Is the Dx & Vx Co Ltd Share Price Today?
The Dx Vx share price today is 2,330.
What Is the Stock Symbol for Dx & Vx Co Ltd
The stock symbol (or 'ticker') for Dx & Vx Co Ltd is "180400."
What Stock Exchange Does Dx & Vx Co Ltd Trade On?
Dx & Vx Co Ltd is listed and trades on the KOSDAQ stock exchange.
Is Dx & Vx Co Ltd a Good Stock to Buy?
Determining whether Dx Vx (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Use the dropdown to select a relevant stock exchange for the current KQ:180400 share price (ISIN: KR7180400004) to enhance your trading decisions with our free investment tools and resources.
What Is the Dx & Vx Co Ltd Share Price Today?
The Dx Vx share price today is 2,330.
What Is the Stock Symbol for Dx & Vx Co Ltd
The stock symbol (or 'ticker') for Dx & Vx Co Ltd is "180400."
What Stock Exchange Does Dx & Vx Co Ltd Trade On?
Dx & Vx Co Ltd is listed and trades on the KOSDAQ stock exchange.
Is Dx & Vx Co Ltd a Good Stock to Buy?
Determining whether Dx Vx (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
KOSDAQ
Currency in KRW
2,330
+65(+2.87%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2,210
2,395
52 wk Range
1,319
5,360
180400 is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2,2102,395
52 wk Range
1,3195,360
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
180400 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Stock has taken a big hit over the last week
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Buy
Moving Averages
Neutral
Earnings
Latest Release
14/08/2026
EPS / Forecast
-57.00 / --
Revenue / Forecast
6.4B / --
Compare 180400 to Peers and Sector
Metrics to compare | 180400 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship180400PeersSector | |
|---|---|---|---|---|
P/E Ratio | −9.1x | −12.1x | −0.4x | |
PEG Ratio | −0.13 | 0.00 | 0.00 | |
Price/Book | 2.8x | 1.5x | 2.6x | |
Price / LTM Sales | 8.8x | 7.1x | 3.0x | |
Upside (Analyst Target) | - | 0.0% | 49.0% | |
Fair Value Upside | Unlock | 11.8% | 6.5% | Unlock |
Dx & Vx Co., Ltd. engages in the development and sale of bio-health care products and provides molecular genetic testing services primarily in South Korea. The company offers healthcare products, including Ofmom Carefree, oat fermented food, and biocleaners; diagnostic products, comprising CLIDEX, precision diagnostics, and in vitro diagnostic kit; health check services; CDx development services; medical data; and funeral home operation services. It provides bacterial vaccine for respiratory disease; macular degeneration drug; atopy dermatitis drugs; xeropthalmia drugs; anticancer vaccine; and new antibody drugs. Its pipeline includes Vx product, oral pediatric Covid19/influenza vaccine; new anti-cancer antibody drug; an antibody drug utilizing advanced mRNA vaccine development technique; Vx Microbiome R&D pipeline, a bacterial vaccine against respiratory diseases, new drugs targeting obesity and diagnosis etc; and Oxford Vacmedix Vaccine, an anti-cancer vaccineutilizing ROP technology. It has a research collaboration with bereum, Bioapp, CORESTEMCHEMON, Genscript PROBIO, JOINTOWN PHARMACEUTICAL GROUP,etc. The company was formerly known as Cancer Rop Co., Ltd. and changed its name to Dx & Vx Co., Ltd. in January 2022. The company was founded in 2001 and is based in Seoul, South Korea.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Dx Vx (KOSDAQ: 180400) Share Price Today?
The Dx Vx stock price today is 2,330 KRW.
What Stock Exchange Does Dx Vx (180400) Trade On?
Dx Vx is listed and trades on the KOSDAQ.
What Is the Ticker (Stock Symbol) for Dx Vx?
The stock symbol (also called a 'ticker') for Dx Vx is "180400."
What Is the Current Dx Vx Market Capitalisation?
As of today, Dx Vx (KOSDAQ: 180400) market cap is 229.34B KRW.
What Is Dx Vx's (180400) Earnings Per Share (TTM)?
The Dx Vx EPS is currently -341 (Trailing Twelve Months).
Is 180400 a Buy or Sell From a Technical Analyst Perspective?
Based on today's Dx Vx moving averages and other technical indicators, the daily buy/sell signal for 180400 stock is Strong Sell.
How Many Times Has Dx Vx Stock Split?
Dx Vx has split 2 times. (See the 180400 stock split history page for full effective split date and price information.)
What is the current trading status of Dx Vx (KOSDAQ: 180400)?
As of 08/09/2026, Dx Vx (180400) is trading at a share price of 2,330 KRW, with a previous close of 2,330 KRW. The stock has fluctuated within a day range of 2,210 KRW to 2,395 KRW, while its 52-week range spans from 1,319 KRW to 5,360 KRW.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.